Elsevier

Virology

Volume 195, Issue 1, July 1993, Pages 292-296
Virology

Short Communications
Neutralization Determinants of United States Bluetongue Virus Serotype Ten

https://doi.org/10.1006/viro.1993.1377Get rights and content

Abstract

A panel of five neutralization-resistant escape mutant (EM) viruses was used to investigate the neutralization determinants of the U.S. prototype strain of bluetongue virus serotype 10 (BTV-10). The phenotypic properties of each EM virus were characterized by neutralization and immuneprecipitation assays with a panel of four monoclonal antibodies (MAbs). These MAbs were used to select the various EM viruses and together the MAbs define four distinct neutralizing epitopes on the prototype strain of BTV-10 (Heidner, H. W., Rositto, P. V., and MacLachlan, N. J., Virology 176, 658-661 (1990)). Sequencing of the L2 gene identified mutations responsible for the altered phenotypic properties exhibited by each EM virus. The L2 gene encodes BTV outer capsid protein VP2 which is responsible for virus neutralization. Four amino acids in three distinct regions of VP2 are critical to expression of the epitopes recognized by the MAb panel. Both amino acid 208 and 211 can affect the binding of MAb 039 and MAb 045, amino acid 327 affects binding of MAb 041, and amino acids 327 and 402 cooperatively interact to affect binding by MAb 034. The location of two of these critical regions on VP2 of BTV-10 is identical to two of those which affect neutralization of Australian BTV-1, despite the fact that these two viruses are antigenically distinct and have divergent L2 gene sequences (Gould, A. R., and Eaton, B. T., Virus Res. 17, 161-172 (1990)). The four individual neutralizing epitopes on VP2 of BTV-10 are interactive (Heidner, H. W., Rositto, P. V., and MacLachlan, N. J., Virology 176, 658-661 (1990)) and at least two are conformationally dependent.

References (0)

Cited by (33)

  • Immunisation with bacterial expressed VP2 and VP5 of bluetongue virus (BTV) protect α/β interferon-receptor knock-out (IFNAR<sup>-/-</sup>) mice from homologous lethal challenge

    2014, Vaccine
    Citation Excerpt :

    However, when both domains were mixed together on an equimolar basis, higher titres of neutralising antibodies were elicited. There is published evidence that neutralisation epitopes are located in the first ∼350 amino acids (domain 1) of VP2 of BTV-10 [56]. IFNAR−/− mice immunised with VP2D1 + VP2D2 and challenged with live BTV-4 survived until the end of the experiment with a transient viraemia (∼0.3–9 pfu/ml detected by RT-PCR only) which was cleared subsequently.

  • The immune response of ruminant livestock to bluetongue virus: From type I interferon to antibody

    2014, Virus Research
    Citation Excerpt :

    Sheep inoculated with VP2 that is either isolated from viral particles or generated by in vitro expression produce virus neutralizing antibodies and are resistant to challenge infection with the homologous BTV serotype (Huismans and Erasmus, 1981; Huismans et al., 1987; Roy et al., 1990, 1992, 1994; Stewart et al., 2012). At least some neutralization epitopes are highly conformationally dependent, reflecting not only folding of the VP2 protein on itself but also its conformational interaction with the other outer capsid protein, VP5 (Appleton and Letchworth, 1983; Cowley and Gorman, 1987; DeMaula et al., 1993, 2000; Gould et al., 1988; Gould and Eaton, 1990; Heidner et al., 1990; Mertens et al., 1989). DeMaula et al. (2000) showed that whereas most variants that were resistant to neutralization with individual neutralizing monoclonal antibodies (MAbs) had amino acid substitutions in key regions of VP2, the VP2 of one MAb-neutralization resistant variant virus was unchanged but this virus had a substitution in VP5, confirming unambiguously the importance of the conformational interaction between VP2 and VP5 in BTV neutralization.

  • Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: Presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection

    2012, Vaccine
    Citation Excerpt :

    The VP2 amino acid sequence similarity between the BTV-1 RSA and GRE2001/07 isolate was 82.1%. Although there were changes to the amino acid sequence, the two regions with the neutralisation epitopes in VP2 [28,29] were conserved in sequence of both BTV-1 isolates (Fig. 2). Twenty-one Karagouniko cross female sheep were divided into 3 groups (I, II and III) and immunized with BTV CLPs (Group I), BTV-1 RSA VLPs (Group II) or saline/saline plus adjuvant (Group III).

View all citing articles on Scopus
View full text